They express features of tumor-initiating CSCs such as a CD44hiCD24lophenotype which confers resistance to cancer therapeutics and enhances metastatic capacity [19] CD44+ tumor cells are able to bind HA through CD44 and HA–CD44 interaction promotes spheroid tumoral formation with growth and self-renewal capabilities. The gene discussed is CD44; the disease is cancer.